tag:blogger.com,1999:blog-7857054149675424609.post4463560110200642126..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: Two Promising RNA Therapeutics to Face Off in Paris ATTR Amyloidosis MeetingDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-7857054149675424609.post-62646151854586136472017-11-02T18:54:33.149+00:002017-11-02T18:54:33.149+00:00Just a confused amateur--
Slide 11/35 I’d be inte...Just a confused amateur--<br />Slide 11/35 I’d be interested in sub-group analysis of (US, JP, DE, TW) vs. everybody else.<br />PBO 22/77 quit, is that a high number?<br />A lot of the pbo were Asian, actually a weirdly high number, why for?<br />North America grossly under-represented in pbo, why for?<br />In the slide presentation, they are so kind as to highlight statistical anomalies in the Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-4583482795104857122017-11-02T17:39:48.455+00:002017-11-02T17:39:48.455+00:00Apparently the Ionis placebo group was healthier w...Apparently the Ionis placebo group was healthier while Apollo had a sicker placebo group (11% mortality?). Was the baseline disease burden of the Apollo placebo arm well distributed, or were some sites or countries outliers that skewed the data?Anonymousnoreply@blogger.com